Skip to main content Help with accessibility Skip to main navigation

Tolvaptan

Indication

Treatment of SIADH for patients not requiring chemotherapy

Grey

Brand:

Samsca

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Endocrine system

Background

Recommendation

LSCMMG Recommendation:

Grey

Reason for decision:

Prioritised for review

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 12 - Sep - 2022